Vaccinex, Inc. SEC filings VCNX
Vaccinex, Inc. has 475 filings in SEC EDGAR's recent list, going back to Nov 12, 2002. Its latest annual report, Form 10-K, was filed on Apr 15, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2024, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Mar 19, 2025 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Filing | Apr 1, 2025 | Mar 31, 2025 |
| 15-12G | Deregistration | Mar 27, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| 25 | Filing | Mar 17, 2025 | — |
| EFFECT | Filing | Oct 24, 2024 | — |
| CORRESP | Letter to the SEC | Oct 22, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 21, 2024 | — |
| D | Filing | Sep 27, 2024 | — |
| EFFECT | Filing | Jul 5, 2024 | — |
| CORRESP | Letter to the SEC | Jul 2, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2024 | — |
| EFFECT | Filing | May 8, 2024 | — |
| CORRESP | Letter to the SEC | May 2, 2024 | — |
| UPLOAD | Letter from the SEC | May 2, 2024 | — |
| EFFECT | Filing | Apr 16, 2024 | — |
| CORRESP | Letter to the SEC | Apr 12, 2024 | — |
| D | Filing | Apr 12, 2024 | — |
| D | Filing | Apr 12, 2024 | — |
| D | Filing | Apr 12, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| NT 10-K | Filing | Apr 2, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Jan 19, 2024 | — |
| CORRESP | Letter to the SEC | Jan 17, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2024 | — |
| EFFECT | Filing | Sep 28, 2023 | — |
| CORRESP | Letter to the SEC | Sep 26, 2023 | — |
| CORRESP | Letter to the SEC | Sep 26, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2023 | — |
| EFFECT | Filing | Jul 10, 2023 | — |
| CORRESP | Letter to the SEC | Jul 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2023 | — |
| EFFECT | Filing | Apr 12, 2023 | — |
| CORRESP | Letter to the SEC | Apr 10, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2023 | — |
| EFFECT | Filing | Jan 31, 2023 | — |
| CORRESP | Letter to the SEC | Jan 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2023 | — |
| EFFECT | Filing | Apr 27, 2022 | — |
| CORRESP | Letter to the SEC | Apr 25, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2022 | — |
| D | Filing | Sep 16, 2020 | — |
| EFFECT | Filing | Aug 25, 2020 | — |
| EFFECT | Filing | Aug 25, 2020 | — |
| CORRESP | Letter to the SEC | Aug 21, 2020 | — |
| CORRESP | Letter to the SEC | Aug 21, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2020 | — |
| D | Filing | Aug 11, 2020 | — |
| D | Filing | Jul 15, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2020 | — |
| EFFECT | Filing | Mar 11, 2020 | — |
| EFFECT | Filing | Mar 11, 2020 | — |
| CORRESP | Letter to the SEC | Mar 9, 2020 | — |
| CORRESP | Letter to the SEC | Mar 9, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2020 | — |
| D | Filing | Feb 3, 2020 | — |
| EFFECT | Filing | Oct 8, 2019 | — |
| CORRESP | Letter to the SEC | Oct 4, 2019 | — |
| CORRESP | Letter to the SEC | Sep 27, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2019 | — |
| D | Filing | Aug 14, 2019 | — |
| EFFECT | Filing | Aug 9, 2018 | — |
| CT ORDER | Filing | Aug 9, 2018 | — |
| CERT | Filing | Aug 8, 2018 | — |
| 8-A12B | Filing | Aug 8, 2018 | — |
| CORRESP | Letter to the SEC | Aug 6, 2018 | — |
| CORRESP | Letter to the SEC | Aug 6, 2018 | — |
| CORRESP | Letter to the SEC | Jul 9, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2018 | — |
| DRSLTR | Filing | Jun 8, 2018 | — |
| DRS/A | Filing | Jun 8, 2018 | — |
| UPLOAD | Letter from the SEC | May 11, 2018 | — |
| DRSLTR | Filing | Apr 13, 2018 | — |
| DRS | Filing | Apr 13, 2018 | — |
| D | Filing | Jul 7, 2017 | — |
| REGDEX | Auto-generated paper document | May 9, 2005 | — |
| REGDEX | Auto-generated paper document | May 9, 2005 | — |
| REGDEX/A | Auto-generated paper document | Mar 8, 2004 | — |
| REGDEX | Auto-generated paper document | Nov 12, 2002 | — |
Showing 93 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VCNX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rochester, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1205922
- Former names
- VACCINEX INC (until May 9, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.